Filter
351
Text search:
art
drug
resistance
Featured
Recommendations
35
New Publications
100
Language
Document type
No document type
242
Guidelines
39
Studies & Reports
34
Manuals
11
Strategic & Response Plan
10
Training Material
8
Fact sheets
6
Infographics
1
Countries / Regions
India
18
Rwanda
12
Western and Central Europe
12
Kenya
11
Tanzania
10
South Africa
9
Eastern Europe
9
Zambia
7
Ethiopia
6
Nepal
6
Bangladesh
6
Malawi
6
Lesotho
5
Myanmar / Burma
5
Latin America and the Carribbean
5
Asia
5
Sierra Leone
4
Ghana
4
Uganda
4
South–East Asia Region
4
Africa
4
Liberia
3
Nigeria
3
Cameroon
3
Philippines
3
Cambodia
3
Pakistan
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Ukraine
2
Eastern Europe and Central Asia
2
Bhutan
2
Albania
2
Russia
2
Georgia
2
Guinea
1
Senegal
1
Zimbabwe
1
Afghanistan
1
Papua New Guinea
1
Botswana
1
Sri Lanka
1
Venezuela
1
Tajikistan
1
Estonia
1
Moldova
1
Global
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
37
Public Health
11
Women & Child Health
9
Capacity Building
6
Key Resources
6
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
HIV
103
TB
84
AMR
12
NTDs
10
Mental Health
8
Caregiver
7
Pharmacy
6
Refugee
5
Ebola & Marburg
2
Polio
2
Malaria
2
Disability
1
Conflict
1
Natural Hazards
1
Social Ethics
1
NCDs
1
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the preval
...
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and inn
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not b
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the
...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.